US Broker Ratings

Beta Bionics, Inc. (BBNX) Stock Analysis: Strong Buy Ratings and 26.9% Upside Potential

Beta Bionics, Inc. (NASDAQ: BBNX), a pioneering medical device company headquartered in Irvine, California, is gaining notable traction in the healthcare sector with its innovative solutions..

Avadel Pharmaceuticals (AVDL) Stock Report: A 3% Upside Amid Robust Revenue Growth

Investors with an eye on the healthcare sector may find Avadel Pharmaceuticals plc (NASDAQ: AVDL) an intriguing opportunity. Based in Ireland, Avadel specializes in drug manufacturing..

CareDx, Inc. (CDNA) Stock Analysis: Exploring a Potential 48.53% Upside for Investors

For investors keen on the healthcare sector, CareDx, Inc. (NASDAQ: CDNA) presents a fascinating opportunity. Specializing in diagnostics and research, CareDx commands a market cap of..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Exploring a 100% Upside Potential for Biotech Investors

Enliven Therapeutics, Inc. (NASDAQ: ELVN) stands out as a compelling opportunity within the healthcare sector, particularly for investors seeking exposure to the biotechnology industry. Headquartered in..

CeriBell, Inc. (CBLL) Stock Analysis: Exploring a 119.70% Potential Upside in the Medical Device Sector

For investors with an affinity for the healthcare sector, particularly those eyeing innovation in medical devices, CeriBell, Inc. (CBLL) presents a compelling case. With a market..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring a Potential 118.71% Upside in Biotechnology

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a promising player in the biotechnology sector, is catching the attention of investors with a substantial potential upside of 118.71%. Specializing..

Zymeworks Inc. (ZYME) Investor Outlook: Strong Buy Ratings and Significant Upside Potential

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, is capturing investor attention with its compelling mix of cutting-edge therapeutic platforms and substantial growth potential. Operating within..

Immunome, Inc. (IMNM) Stock Analysis: A Biotech Contender with a 49% Potential Upside

Immunome, Inc. (NASDAQ: IMNM) is drawing investor attention with its promising potential upside of nearly 50%, as noted by analysts’ target price evaluations. As a clinical-stage..

Bicara Therapeutics Inc. (BCAX) Growth Potential: Analyst Ratings Signal 89.97% Upside

Bicara Therapeutics Inc. (NASDAQ: BCAX), a burgeoning player in the biotechnology sector, is capturing the attention of investors with a compelling growth narrative and an impressive..

CureVac N.V. (CVAC) Stock Analysis: Navigating the mRNA Landscape with a 40.22% ROE

CureVac N.V. (NASDAQ: CVAC) is a biopharmaceutical company that has caught the attention of investors with its innovative approach to developing transformative medicines based on messenger..

InMode Ltd. (INMD) Stock Analysis: Unveiling Growth Potential and Strategic Market Position

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, particularly in the medical devices industry, is gaining attention in the investment community for its..

Intellia Therapeutics (NTLA) Stock Analysis: Examining a 33.51% Potential Upside Amid Rapid Revenue Growth

As the biotechnology landscape continues to evolve, investors are increasingly turning their attention to Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering force in the gene editing..

Workday, Inc. (WDAY) Stock Analysis: A Strong Buy with 16% Upside Potential

Workday, Inc. (NASDAQ: WDAY), a leader in the enterprise cloud applications sector, continues to capture investor attention with its robust market presence and significant growth potential...

Alarm.com Holdings, Inc. (ALRM) Stock Analysis: Assessing the 34.63% Potential Upside

Alarm.com Holdings, Inc. (NASDAQ: ALRM), a prominent player in the technology sector, is making waves in the software application industry with its innovative Internet of Things..

Mitek Systems, Inc. (MITK) Stock Analysis: Potential 37% Upside Attracts Investor Attention

For investors eyeing the technology sector, Mitek Systems, Inc. (NASDAQ: MITK) presents a compelling opportunity, particularly given the potential upside of 37.28% based on current analyst..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Undervalued Tech Play with 59% Upside Potential

DoubleVerify Holdings, Inc. (DV), a notable player in the technology sector, is carving out a significant niche within the software application industry. Renowned for its media..

Investor Outlook: Paycom Software, Inc. (PAYC) Offers Nearly 20% Upside Potential Amid Robust HCM Solutions

Paycom Software, Inc. (NASDAQ: PAYC), a prominent player in the technology sector, particularly within the software application industry, continues to capture investor attention with its sophisticated..

Intuit Inc. (INTU) Stock Analysis: Exploring a 21% Upside Amid Robust Revenue Growth

For investors eyeing potential opportunities within the technology sector, Intuit Inc. (NASDAQ: INTU) presents a compelling case. With a market capitalization of $187.01 billion, Intuit continues..

Dynatrace, Inc. (DT) Stock Analysis: Evaluating a 27% Potential Upside in the Tech Sector

Dynatrace, Inc. (NYSE: DT) stands out in the technology sector with a compelling growth narrative driven by its innovative AI-powered observability platform. As a leader in..

Autodesk, Inc. (ADSK) Stock Analysis: Strong Buy Ratings and 18% Potential Upside

Autodesk, Inc. (NASDAQ: ADSK), a leader in the technology sector specializing in software applications, continues to capture investor attention with its robust performance metrics and optimistic..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds